Skip to content

Biofeedback therapy and psychological dredging therapy for oral mucosal diseases

The assisstant effect of biofeedback therapy on burning mouth syndrome and its’ effect on patients’ electroencephalogram

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17011739
Enrollment
Unknown
Registered
2017-06-22
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burning mouth syndrome

Interventions

The control group:Oryzanol Tablets, oral taken, 10mg/ time, 3 times / day
The experimental group:Oryzanol Tablets, oral taken, 10mg/ time, 3 times/day
vitamin B2 tablets, oral taken, 10mg/time, 3 times/day
vitamin E pills, oral taken, 100mg/ time, 1 times/day, taking 1 months as a course. On the basis of the triple drug therapy, the experimental group was treated with biofeedback
vitamin B2 tablets, oral taken, 10mg/ time, 3 times / day
vitamin E pills, oral taken, 100mg/ time, 1 times / day, taking 1 months as a course.

Sponsors

Sichuan University, West China Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) People aged 18-65 years; (2) Through the detailed inquiry of the medical history, the symptoms and signs do not meet the clinical characteristics can be diagnosed as BMS, >6 months of history; (3) There is no revision local irritant of burning pain in the mouth; (4) The whole blood chart, blood sugar, liver and kidney function, routine urine test, abdominal ultrasound examination, chest X-ray examination and other basic physical examination items were normal; (5) In order to improve sleep occasionally take sleeping or hypnotic drugs; (6) Volunteer to participate in this experiment and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) There are local irritation factors which can cause burning pain in the mouth (including bad restoration, sharp teeth tip, tooth ridge, complete denture, etc.); (2) Suffer from other serious oral mucosal diseases (including oral candidiasis, oral lichen planus, all kinds of oral ulcers, bullous diseases, etc.); (3) Patients with serious systemic diseases (heart disease, kidney disease, hypertension, diabetes mellitus, etc.); (4)Patients who received routine medication because of neurological dysfunction or mental disorders (diagnosed by specialist outpatient clinic of 3A Hospitals); (5) Scalp infections may affect electrode installers; (6) Patients with organic lesions in the brain (such as brain tumors, cerebral hemorrhage, etc.); (7) Pregnant women or lactating women; (8) Low cognitive level, unable to correctly understand and fill out questionnaires; (9) Unable to comply with the doctor's instructions or unable to return the patient on time.

Design outcomes

Primary

MeasureTime frame
Pain index;Effective sleep time;Anxiety/Depression index;

Countries

China

Contacts

Public ContactZhou Hongmei

West China Hospital of Stomatology, Sichuan University

acomnet@126.com+86 028-85503480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026